Regeltec Inc News Today

BALTIMORE--(BUSINESS WIRE)--Sep 28, 2023--

A Leader in University Academics

This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,...

/PRNewswire/ -- An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back...

Prospect of a potential new treatment for low back pain with preliminary results from an experimental hydrogel injected into degenerated spinal discs

An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back pain caused by degenerative disc disease (DDD), according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting, in Boston.

Colombia has a population of approximately 50 million inhabitants, making it the third most populous country in Latin America after Mexico and Brazil.

Colombia has a population of approximately 50 million inhabitants, making it the third most populous country in Latin America after Mexico and Brazil.

Posted on 378 ReGelTec, Inc., a medical device company developing a percutaneous treatment for chronic low back pain, announced today that it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA). The company’s leading product is HYDRAFIL™, a patented hydrogel that is heated prior to injection into the nucleus of a degenerated disc vi...